HK1202112A1 - Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase - Google Patents
Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyraseInfo
- Publication number
- HK1202112A1 HK1202112A1 HK15102491.3A HK15102491A HK1202112A1 HK 1202112 A1 HK1202112 A1 HK 1202112A1 HK 15102491 A HK15102491 A HK 15102491A HK 1202112 A1 HK1202112 A1 HK 1202112A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyrrolopyrimidone
- pyrrolopyridone
- tankyrase
- inhibitors
- pyrrolopyridone inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261656650P | 2012-06-07 | 2012-06-07 | |
PCT/EP2013/061525 WO2013182580A1 (en) | 2012-06-07 | 2013-06-05 | Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1202112A1 true HK1202112A1 (en) | 2015-09-18 |
Family
ID=48628628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102491.3A HK1202112A1 (en) | 2012-06-07 | 2015-03-11 | Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase |
Country Status (13)
Country | Link |
---|---|
US (1) | US8722661B2 (ja) |
EP (1) | EP2858995A1 (ja) |
JP (1) | JP2015522557A (ja) |
KR (1) | KR20150005711A (ja) |
CN (1) | CN104350056A (ja) |
AR (1) | AR091271A1 (ja) |
BR (1) | BR112014030416A2 (ja) |
CA (1) | CA2873723A1 (ja) |
HK (1) | HK1202112A1 (ja) |
MX (1) | MX2014014832A (ja) |
RU (1) | RU2014151004A (ja) |
TW (1) | TW201402576A (ja) |
WO (1) | WO2013182580A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014MN01875A (ja) | 2012-03-07 | 2015-07-03 | Cancer Res Inst Royal | |
RU2014152790A (ru) * | 2012-06-20 | 2016-08-10 | Ф. Хоффманн-Ля Рош Аг | Пирролопиразоновые ингибиторы танкиразы |
ES2666729T3 (es) | 2013-09-11 | 2018-05-07 | Institute Of Cancer Research: Royal Cancer Hospital (The) | Compuestos de isoquinolin-1-ona 3-aril-5-sustituida y su uso terapéutico |
KR101921486B1 (ko) | 2014-04-10 | 2018-11-26 | 후베이 바이오-파마슈티컬 인더스트리얼 테크놀로지컬 인스티튜트 인크. | PARP억제제인 4H-피라졸로[1,5-a]벤즈이미다졸 화합물의 아날로그 |
KR101739003B1 (ko) * | 2014-07-11 | 2017-05-23 | 에스티팜 주식회사 | 신규한 트리아졸로피리미디논 또는 트리아졸로피리디논 유도체, 및 이들의 용도 |
WO2016006975A2 (en) * | 2014-07-11 | 2016-01-14 | St Pharm Co., Ltd. | Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof |
KR20160007347A (ko) | 2014-07-11 | 2016-01-20 | 에스티팜 주식회사 | 신규한 이미다조트리아지논 또는 이미다조피라지논 유도체, 및 이들의 용도 |
WO2016006974A2 (en) * | 2014-07-11 | 2016-01-14 | St Pharm Co., Ltd. | Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof |
US10722484B2 (en) | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
CN107286169B (zh) * | 2016-04-05 | 2020-11-24 | 北京四环制药有限公司 | 端锚聚合酶抑制剂 |
US11414429B2 (en) | 2016-06-30 | 2022-08-16 | Riken | Compound or pharmaceutically acceptable salt thereof |
WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
US11566017B2 (en) | 2017-12-27 | 2023-01-31 | Riken | Dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor |
WO2019131794A1 (ja) | 2017-12-27 | 2019-07-04 | 公益財団法人がん研究会 | 抗がん剤 |
CA3239086A1 (en) * | 2021-12-01 | 2023-06-08 | St Pharm Co., Ltd. | Method for preparing triazolopyrimidinone derivative |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6200980B1 (en) * | 1995-06-07 | 2001-03-13 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl purinone derivatives |
BR9911612A (pt) * | 1998-06-02 | 2001-02-06 | Osi Pharm Inc | Composições de pirrolo[2,3d]pirimidina e seus usos |
US6878716B1 (en) * | 1998-06-02 | 2005-04-12 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptor and uses thereof |
AU784878B2 (en) * | 1999-12-02 | 2006-07-13 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 A2A and A3 receptors and uses thereof |
CA2396276A1 (en) * | 2000-01-07 | 2001-07-12 | Universitaire Instelling Antwerpen | Purine derivatives, process for their preparation and use thereof |
YU42703A (sh) * | 2000-12-01 | 2006-03-03 | Osi Pharmaceuticals Inc. | Jedinjenja specifična za dobijanje adenozinske a1,a2a i a3 receptore i njihove primene |
WO2002094790A1 (fr) * | 2001-05-23 | 2002-11-28 | Mitsubishi Pharma Corporation | Compose heterocyclique condense et son utilisation medicale |
CN100374441C (zh) * | 2003-06-06 | 2008-03-12 | 天津倍方科技发展有限公司 | 二氢吡咯[2,3-d]嘧啶-4-酮衍生物,其制备方法及其制药用途 |
US8080557B2 (en) * | 2004-06-30 | 2011-12-20 | Janssen Pharmaceutica, Nv | Quinazolinedione derivatives as PARP inhibitors |
NZ546477A (en) | 2006-04-07 | 2009-04-30 | Auckland Uniservices Ltd | 4-Alkylamino-2-(heterocyclic)quinazolines and their use in cancer therapy |
AR070127A1 (es) * | 2008-01-11 | 2010-03-17 | Novartis Ag | Pirrolo - pirimidinas y pirrolo -piridinas |
WO2009153261A1 (en) * | 2008-06-18 | 2009-12-23 | Solvay Pharmaceuticals Gmbh | HYDROXYPHENYL-SUBSTITUTED PYRROLO[2,3d]PYRIMIDINE DERIVATIVES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
WO2010011620A1 (en) | 2008-07-21 | 2010-01-28 | Wyeth | 4-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine and n-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
KR20110071098A (ko) | 2008-09-30 | 2011-06-28 | 아스트라제네카 아베 | 복소환 jak 키나제 억제제 |
WO2010066629A2 (en) | 2008-12-09 | 2010-06-17 | F. Hoffmann-La Roche Ag | Novel azaindoles |
US20110275707A1 (en) * | 2008-12-19 | 2011-11-10 | Kuo-Hsiung Lee | Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents |
AR079814A1 (es) * | 2009-12-31 | 2012-02-22 | Otsuka Pharma Co Ltd | Compuestos heterociclicos, composiciones farmaceuticas que los contienen y sus usos |
EP2858994A1 (en) * | 2012-06-07 | 2015-04-15 | F. Hoffmann-La Roche AG | Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase |
-
2013
- 2013-06-05 MX MX2014014832A patent/MX2014014832A/es unknown
- 2013-06-05 JP JP2015515503A patent/JP2015522557A/ja active Pending
- 2013-06-05 BR BR112014030416A patent/BR112014030416A2/pt not_active IP Right Cessation
- 2013-06-05 CA CA2873723A patent/CA2873723A1/en not_active Abandoned
- 2013-06-05 WO PCT/EP2013/061525 patent/WO2013182580A1/en active Application Filing
- 2013-06-05 RU RU2014151004A patent/RU2014151004A/ru unknown
- 2013-06-05 EP EP13729285.0A patent/EP2858995A1/en not_active Withdrawn
- 2013-06-05 AR ARP130101978 patent/AR091271A1/es unknown
- 2013-06-05 KR KR1020147034216A patent/KR20150005711A/ko not_active Application Discontinuation
- 2013-06-05 CN CN201380028055.7A patent/CN104350056A/zh active Pending
- 2013-06-06 US US13/911,601 patent/US8722661B2/en not_active Expired - Fee Related
- 2013-06-06 TW TW102120184A patent/TW201402576A/zh unknown
-
2015
- 2015-03-11 HK HK15102491.3A patent/HK1202112A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20130331375A1 (en) | 2013-12-12 |
TW201402576A (zh) | 2014-01-16 |
AR091271A1 (es) | 2015-01-21 |
US8722661B2 (en) | 2014-05-13 |
BR112014030416A2 (pt) | 2017-06-27 |
CN104350056A (zh) | 2015-02-11 |
JP2015522557A (ja) | 2015-08-06 |
MX2014014832A (es) | 2015-02-12 |
RU2014151004A (ru) | 2016-08-10 |
KR20150005711A (ko) | 2015-01-14 |
EP2858995A1 (en) | 2015-04-15 |
CA2873723A1 (en) | 2013-12-12 |
WO2013182580A1 (en) | 2013-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180953T1 (hr) | Supstituirani 3-haloalilaminski inhibitori za ssao i njihove uporabe | |
HRP20181628T1 (hr) | Spojevi i postupci za njihovu upotrebu | |
HK1202112A1 (en) | Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase | |
IL237849B (en) | ret suppressors and their uses | |
HK1208439A1 (en) | 5-azaindazole compounds and methods of use 5- | |
HK1213889A1 (zh) | 殼氨醯胺酶抑制劑及使用方法 | |
HK1202333A1 (en) | Combination of kinase inhibitors and uses thereof | |
EP2678018A4 (en) | COMBINATION OF CHINESE HEMMER AND USES THEREOF | |
ZA201502503B (en) | Hppd variants and methods of use | |
EP2912178A4 (en) | SUPER AMPLIFIER AND METHOD FOR USE THEREOF | |
HUE043853T2 (hu) | GSK3 inhibitorok és eljárások azok alkalmazására | |
HK1206264A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3- | |
HK1207968A1 (en) | Usp30 inhibitors and methods of use usp30 | |
EP2852397A4 (en) | HUWENTOXIN IV VARIANTS AND METHODS OF USE | |
HK1206282A1 (en) | Tfpi inhibitors and methods of use tfpi | |
EP2809662A4 (en) | INHIBITORS OF RIBONUCLEOTIDE REDUCTASE AND METHODS OF USE | |
HK1201066A1 (en) | Pyranopyridone inhibitors of tankyrase | |
EP2688901A4 (en) | INHIBITORS OF 17SS-HSD1, 17SS-HSD3 AND 17SS-HSD10 | |
ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
EP2841164A4 (en) | COMPOSITIONS AND USE PROCEDURES FOR THE SKIN |